<qa>  What is the purpose of the study?The purpose of the study is to determine the tolerability, the initial safety profile and maximum tolerated dose, and to obtain preliminary information on the antitumor activity of inotuzumab ozogamicin CMC-544 in combination with rituximab in subjects with follicular, diffuse large B-Cell, or mantle cell NHL. 